• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sequential first-pass elimination of a metabolite derived from a precursor.

作者信息

Pang K S, Gillette J R

出版信息

J Pharmacokinet Biopharm. 1979 Jun;7(3):275-90. doi: 10.1007/BF01060018.

DOI:10.1007/BF01060018
PMID:480149
Abstract

We examined data from our previous studies in which we not only delivered perfusate containing tracer concentrations of [14C]phenacetin and its metabolite [3H]acetaminophen under constant perfusate flow (10 ml/min/liver) into the rat liver preparation just once, but also recirculated fresh reservoir perfusate containing a tracer dose of [14C]phenacetin through the same rat liver preparation. From the single-pass studies, estimates of fm, the fractional rate of conversion for [14C]phenacetin to form [14C]acetaminophen, and F(M.P), the apparent availability of [14C]acetaminophen, were obtained by determining the concentrations of [14C]acetaminophen in the perfusate before and after incubation with Glusulase. These estimates were fm = 0.871 +/- 0.16 and F(M.P) = 0.43 +/- 0.10. These and the steady-state clearance values of phenacetin (9.1 +/- 0.8 ml/min) and acetaminophen (6.7 +/- 0.7 ml/min) from the single-pass studies were used to predict the concentrations of [14C]acetaminophen in the reservoir perfusate on recirculation of [14C]phenacetin. We found that the sequential first-pass elimination of the metabolite must be considered when the metabolite is highly extracted by the liver. If we had neglected to take this into account, the fractional rate of conversion of a precursor to form a metabolite and the rate of formation of the metabolite would have been underestimated by the factor F(M.P).

摘要

相似文献

1
Sequential first-pass elimination of a metabolite derived from a precursor.
J Pharmacokinet Biopharm. 1979 Jun;7(3):275-90. doi: 10.1007/BF01060018.
2
Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin.灌注大鼠肝脏制剂中代谢物形成与消除的动力学:预先形成的对乙酰氨基酚与由非那西丁形成的对乙酰氨基酚在消除方面的差异。
J Pharmacol Exp Ther. 1978 Oct;207(1):178-94.
3
Metabolite kinetics: formation of acetaminophen from deuterated and nondeuterated phenacetin and acetanilide on acetaminophen sulfation kinetics in the perfused rat liver preparation.代谢物动力学:在灌注大鼠肝脏制剂中,由氘代和非氘代非那西丁及乙酰苯胺生成对乙酰氨基酚对其硫酸化动力学的影响。
J Pharmacol Exp Ther. 1982 Jul;222(1):14-9.
4
Retrograde perfusion to probe the heterogeneous distribution of hepatic drug metabolizing enzymes in rats.逆行灌注法探究大鼠肝脏药物代谢酶的异质性分布
J Pharmacol Exp Ther. 1981 Feb;216(2):339-46.
5
Effects of perfusate flow rate on measured blood volume, disse space, intracellular water space, and drug extraction in the perfused rat liver preparation: characterization by the multiple indicator dilution technique.灌注液流速对灌注大鼠肝脏标本中测量的血容量、组织间隙、细胞内水间隙和药物提取的影响:采用多指示剂稀释技术进行表征
J Pharmacokinet Biopharm. 1988 Dec;16(6):595-632. doi: 10.1007/BF01062014.
6
Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted.对乙酰氨基酚和非那西丁在分离的大鼠肝细胞中的代谢。一种肝脏固有的空间组织被破坏的系统。
Drug Metab Dispos. 1985 Jan-Feb;13(1):42-50.
7
Phenacetin and acetaminophen metabolism in the isolated perfused rat liver. Precursor concentration influences the selection of kinetic parameters to assess hypoxic impairment.
Drug Metab Dispos. 1991 Mar-Apr;19(2):423-9.
8
Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver.肝动脉在非那西丁和对乙酰氨基酚代谢中的作用:灌注大鼠肝脏的活体显微镜检查和多指标稀释研究
Hepatology. 1994 Sep;20(3):672-83.
9
A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics.
J Pharmacokinet Biopharm. 1986 Jun;14(3):289-308. doi: 10.1007/BF01106708.
10
Reactive metabolites of phenacetin and acetaminophen: a review.非那西丁和对乙酰氨基酚的反应性代谢产物:综述
Environ Health Perspect. 1983 Mar;49:71-9. doi: 10.1289/ehp.834971.

引用本文的文献

1
Pharmacokinetics of cannabidiol, (-)--Δ-tetrahydrocannabinol, and their oxidative metabolites after intravenous and oral administration of a cannabidiol-dominant full-spectrum hemp product to beagle dogs.在向比格犬静脉注射和口服一种以大麻二酚为主的全谱大麻产品后,大麻二酚、(-)-Δ-四氢大麻酚及其氧化代谢物的药代动力学。
Front Vet Sci. 2025 Apr 8;12:1556975. doi: 10.3389/fvets.2025.1556975. eCollection 2025.
2
Prediction of relative in vivo metabolite exposure from in vitro data using two model drugs: dextromethorphan and omeprazole.利用两种模型药物:右美沙芬和奥美拉唑预测体内相对代谢物暴露。
Drug Metab Dispos. 2012 Jan;40(1):159-68. doi: 10.1124/dmd.111.042200. Epub 2011 Oct 18.
3

本文引用的文献

1
Pharmacokinetics of salicylate elimination in man.人体中水杨酸盐消除的药代动力学。
J Pharm Sci. 1965 Jul;54(7):959-67. doi: 10.1002/jps.2600540703.
2
Pharmacokinetic model for chlordiazepoxide--HCl in the dog.狗体内氯氮䓬盐酸盐的药代动力学模型。
J Pharm Sci. 1970 Nov;59(11):1569-74. doi: 10.1002/jps.2600591105.
3
Clearance concepts in pharmacokinetics.药代动力学中的清除概念。
Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.
基于生理学的吸收、转运、代谢和排泄的药代动力学模型。
J Pharmacokinet Pharmacodyn. 2010 Dec;37(6):591-615. doi: 10.1007/s10928-010-9185-x. Epub 2010 Dec 14.
4
Physiological modeling to understand the impact of enzymes and transporters on drug and metabolite data and bioavailability estimates.生理建模以了解酶和转运体对药物和代谢物数据及生物利用度评估的影响。
Pharm Res. 2010 Jul;27(7):1237-54. doi: 10.1007/s11095-010-0049-2. Epub 2010 Apr 6.
5
New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.新型抗惊厥药物。重点介绍氟桂利嗪、磷苯妥英、咪达唑仑和司替戊醇。
Drugs. 1994 Aug;48(2):153-71. doi: 10.2165/00003495-199448020-00003.
6
Metabolite to parent drug concentration ratio as a function of parent drug extraction ratio: cases of nonportal route of administration.
J Pharmacokinet Biopharm. 1981 Aug;9(4):489-96. doi: 10.1007/BF01060891.
7
Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites.代谢物药代动力学:肾清除和肝清除药物及代谢物经不同给药途径给药后代谢物的曲线下面积和药物代谢分数率。
J Pharmacokinet Biopharm. 1981 Aug;9(4):477-87. doi: 10.1007/BF01060890.
8
Pharmacokinetics of triamterene and its metabolite in man.氨苯蝶啶及其代谢物在人体中的药代动力学。
J Pharmacokinet Biopharm. 1982 Oct;10(5):507-23. doi: 10.1007/BF01059034.
9
Drug metabolite concentration-time profiles: influence of route of drug administration.药物代谢物浓度-时间曲线:给药途径的影响
Br J Clin Pharmacol. 1984 Apr;17(4):385-94. doi: 10.1111/j.1365-2125.1984.tb02362.x.
10
An understanding of the role of enzyme localization of the liver on metabolite kinetics: a computer simulation.
J Pharmacokinet Biopharm. 1983 Oct;11(5):451-68. doi: 10.1007/BF01062205.
J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36. doi: 10.1007/BF01059626.
4
Renal contribution to overall metabolism of drugs. II. Biotransformation of salicylic acid to salicyluric acid.肾脏对药物整体代谢的作用。II. 水杨酸向水杨尿酸的生物转化。
J Pharm Sci. 1972 Aug;61(8):1284-7. doi: 10.1002/jps.2600610823.
5
Pharmacokinetics of isoniazid and some metabolites in man.异烟肼及其某些代谢产物在人体中的药代动力学。
J Pharmacokinet Biopharm. 1976 Aug;4(4):287-325. doi: 10.1007/BF01063121.
6
Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin.灌注大鼠肝脏制剂中代谢物形成与消除的动力学:预先形成的对乙酰氨基酚与由非那西丁形成的对乙酰氨基酚在消除方面的差异。
J Pharmacol Exp Ther. 1978 Oct;207(1):178-94.
7
Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism.
J Pharm Sci. 1978 May;67(5):703-4. doi: 10.1002/jps.2600670536.
8
Hepatic clearance of drugs. III. Additional experimental evidence supporting the "well-stirred" model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liver in situ preparation.药物的肝清除率。III. 额外的实验证据支持“充分搅拌”模型,该证据来自于在不同肝血流速率及灌注大鼠原位肝制备的线性条件下,由利多卡因产生的代谢物(MEGX)。
J Pharmacokinet Biopharm. 1977 Dec;5(6):681-99. doi: 10.1007/BF01059690.
9
Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.药物的肝清除率。I. “充分搅拌”模型和“平行管”模型的理论考量。肝血流量、血浆和血细胞结合以及肝细胞酶活性对肝药物清除率的影响。
J Pharmacokinet Biopharm. 1977 Dec;5(6):625-53. doi: 10.1007/BF01059688.